Early research (Phase 1)Study completedNCT00098163
What this trial is testing
Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60